News | March 06, 2023
Par Drugs and Chemicals receives WHO-GMP certificate
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The company operates 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory, and 95 Collection Centers
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
Rocuronium Bromide Injection is a neuromuscular blocking agent
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Subscribe To Our Newsletter & Stay Updated
